# Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme

> **NCT02844062** · PHASE1 · UNKNOWN · sponsor: **Beijing Sanbo Brain Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **BIOLOGICAL:** anti-EGFRvIII CAR T cells
- **DRUG:** cyclophosphamide
- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT02844062
- **Lead sponsor:** Beijing Sanbo Brain Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2018-07
- **Final completion:** 2019-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02844062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02844062, "Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02844062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*